Summary
The present project seeks to further consolidate the rationale for replacing HLA-partially-matched HSCT with a gene therapy approach to treat PIDs and to explore new strategies of gene modification by gene-editing technology.
More information & hyperlinks
| Web resources: | http://institutimagine.org |